Donidalorsen for the Treatment of Hereditary Angioedema: A Review of Clinical Studies.

Drug Des Devel Ther · 2026 · PMC13340341 · PMID 42415941

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nominally significantno p-value reported

26 , 57 In OASIS-HAE, patients reported nominally significant improvements in the Functioning, Fears/Shame, and Nutrition domains in both the donidalorsen Q4W and Q8W groups vs placebo. 76 Overall, the clinical data show that patients broadly report increased quality of life while receiving donidalorsen treatment.

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.